COMBINATION THERAPY FOR RNA VIRUS INFECTIONS INVOLVING RIBAVIRIN AND IMPDH INHIBITORS

Details for Australian Patent Application No. 2003249659 (hide)

Owner SCHERING CORPORATION

Inventors REYES, Gregory, R.; ZHOU, Sifang; MALCOLM, Bruce, A.

Pub. Number AU-A-2003249659

PCT Number PCT/US03/16891

PCT Pub. Number WO2003/101199

Priority 60/384,658 31.05.02 US; 60/405,546 22.08.02 US

Filing date 30 May 2003

Wipo publication date 19 December 2003

International Classifications

A01N 043/76 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 031/42 - Oxazoles

C07D 263/02 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/34 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/384,658 31.05.02 US; 60/405,546 22.08.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-A-2003249659

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003249660-ULTRASONIC LIQUID FUEL INTRODUCTION SYSTEM

2003249658-XANTHINE PHOSPHODIESTERASE V INHIBITOR POLYMORPHS